Trial to Evaluate UltraSound in the Treatment of Tibial Fractures (TRUST)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00667849 |
Recruitment Status :
Terminated
(Study was terminated due to futility)
First Posted : April 28, 2008
Results First Posted : December 8, 2015
Last Update Posted : December 8, 2015
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Tibial Fractures | Device: Exogen 4000+ Device: Sham | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 501 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Trial to Evaluate UltraSound in the Treatment of Tibial Fractures |
Study Start Date : | September 2008 |
Actual Primary Completion Date : | December 2012 |
Actual Study Completion Date : | December 2012 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Exogen 4000+
Single arm, Exogen 4000+
|
Device: Exogen 4000+
Low-intensity pulsed ultrasound (LIPUS)
Other Name: Exogen Bone Healing System - 4000+ series |
Sham Comparator: Sham
Single arm, sham (identical device with the exception of administration of ultrasound).
|
Device: Sham
sham device identical to active device with the exception of administration of ultrasound
Other Name: Single arm, sham of the Exogen 4000+ |
- Change From Baseline in the SF-36 Physical Component Summary (PCS) Score of the Short Form-36 (SF-36) [ Time Frame: Over 365 days ]Assessments at baseline and 6 post baseline time points/ mixed effects repeated measure single point estimate. Range= -100 worst, 0 best
- Time (Days) to Radiographic Healing of Tibial Fractures [ Time Frame: over 365 days ]Days from randomization to day of x-ray assessed healed or, if not healed, day of premature withdrawal/study termination or day 365 (end of study visit)/ Kaplan-Meier
- Treatment Compliance [ Time Frame: Treatment period: Days from randomization to day of x-ray assessed healed or, if not heal, day of premature withdrawal/study termination or day 365 (end of study visit) ]The percent of subjects who used the device greater than or equal to 18 minutes per day over 80% of the days in their treatment period.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Males and females age 18 years or older
- Have an open or closed tibial fracture amenable to intramedullary nail fixation
Exclusion Criteria:
- Tibial fracture associated with a vascular injury requiring repair
- Pilon fractures
- Tibial fractures that extend into the joint and require reduction
- Pathologic fractures • Bilateral tibial fractures

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00667849
United States, California | |
San Francisco General/Dept of Orthopedic Surgery | |
San Francisco, California, United States, 94110 | |
United States, Florida | |
Florida Orthopedic Institute | |
Tampa, Florida, United States, 33606 | |
United States, Indiana | |
OrthoIndy | |
Indianapolis, Indiana, United States, 46202 | |
United States, Kentucky | |
University of Kentucky | |
Lexington, Kentucky, United States, 50436 | |
United States, Maine | |
Eastern Maine Medical Center | |
Bangor, Maine, United States, 04401 | |
United States, Missouri | |
University of Missouri | |
Columbia, Missouri, United States, 65212 | |
United States, New York | |
Insall Scott Kelly Institute | |
New York, New York, United States, 10065 | |
United States, North Carolina | |
Duke University Medical Center | |
Durham, North Carolina, United States, 27710 | |
United States, Pennsylvania | |
Rothman Institute | |
Philadelphia, Pennsylvania, United States, 19107 | |
Temple University Hospital | |
Philadelphia, Pennsylvania, United States, 19140 | |
United States, South Carolina | |
Greenville Hospital System | |
Greenville, South Carolina, United States, 29605 | |
United States, Texas | |
Orthopedic Specialtiy Associates | |
Fort Worth, Texas, United States, 76104 | |
United States, West Virginia | |
West Virginia University | |
Morgantown, West Virginia, United States, 26506 | |
Canada, Alberta | |
Foothills Medical Centre | |
Calgary, Alberta, Canada, T2N 2T9 | |
Canada, British Columbia | |
Vancouver Coastal Health | |
Vancouver, British Columbia, Canada, V5Z 1M9 | |
Canada, Nova Scotia | |
QE II Health Sciences Centre | |
Halifax, Nova Scotia, Canada |
Principal Investigator: | Mohit Bhandari, MD | McMaster University |
Responsible Party: | Bioventus LLC |
ClinicalTrials.gov Identifier: | NCT00667849 |
Other Study ID Numbers: |
EX-TIB-0907 |
First Posted: | April 28, 2008 Key Record Dates |
Results First Posted: | December 8, 2015 |
Last Update Posted: | December 8, 2015 |
Last Verified: | November 2015 |
Tibia |
Fractures, Bone Tibial Fractures Wounds and Injuries Leg Injuries |